⌘K

Login Start Free

FENNEC PHARMACEUTICALS INC.·4

Apr 18, 9:43 PM ET

Haigh Adrian 4

4 · FENNEC PHARMACEUTICALS INC. · Filed Apr 18, 2024

Insider Transaction Report

Form 4

Period: 2024-04-17

FENNEC PHARMACEUTICALS INC.FENC

Director

Transactions

Sale
Common Shares
2024-04-17$2.31/sh+22,222$51,333→ 22,222 total
Sale
Common Shares
2024-04-18$2.31/sh+22,222$51,333→ 44,444 total
Sale
Common Shares
2024-04-17$9.91/sh−22,222$220,220→ 22,222 total
Sale
Common Shares
2024-04-18$9.62/sh−22,222$213,776→ 0 total
Exercise/Conversion
Common Shares
2024-04-17$2.31/sh−22,222$51,333→ 449,135 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)
Exercise/Conversion
Common Shares
2024-04-18$2.31/sh−22,222$51,333→ 426,913 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)

Footnotes (6)

[F1]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F2]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F3]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
[F4]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
[F5]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
[F6]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.

Documents

1 file

4
form4-04192024_010425.xmlPrimary